Bill of Health

OCTOBER 26, 2023

By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over. As reasonable and evidence-based adjustments to prevent transmission and protect health became the norm, authorities continued to fail on equity.

COVID-19 299

COVID-19 Public Health Pharmaceutical Industry World Health 299

Bill of Health

DECEMBER 12, 2023

By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. This, critically, could have helped save lives.

COVID-19 Vaccine 144

COVID-19 Vaccine COVID-19 Pharmaceutical Industry Public Health 144

Bill of Health

AUGUST 29, 2022

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”

COVID-19 Vaccine 362

COVID-19 Vaccine COVID-19 Licensing Governance 362

SQA

FEBRUARY 26, 2024

It provides a practical guide for the pharmaceutical industry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines. Recommendations for stability studies.

FDA 52

FDA Compliance COVID-19 Public Health 52